Eldridge Investment Advisors, Inc. Abbott Laboratories Transaction History

Eldridge Investment Advisors, Inc.

$426 Million
Q3 2024

A detailed history of Eldridge Investment Advisors, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Eldridge Investment Advisors, Inc. holds 8,449 shares of ABT stock, worth $965,129. This represents 0.23% of its overall portfolio holdings.

Number of Shares

8,449

Previous 8,447 0.02%

Holding current value

$965,129

Previous $878,000 9.68%

% of portfolio

0.23%

Previous 0.22%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$100.07 - $118.13 $200 - $236	2 Added 0.02%	8,449 $963,000
Q2 2024 Aug 01, 2024	BUY	$100.73 - $112.44 $23,268 - $25,973	231 Added 2.81%	8,447 $878,000
Q1 2024 May 10, 2024	BUY	$109.52 - $120.96 $4,161 - $4,596	38 Added 0.46%	8,216 $934,000
Q4 2023 Feb 06, 2024	SELL	$90.19 - $110.4 $9,560 - $11,702	-106 Reduced 1.28%	8,178 $900,000
Q3 2023 Nov 06, 2023	BUY	$95.53 - $114.62 $191 - $229	2 Added 0.02%	8,284 $802,000
Q2 2023 Aug 03, 2023	SELL	$100.78 - $112.29 $55,227 - $61,534	-548 Reduced 6.21%	8,282 $903,000
Q1 2023 May 12, 2023	BUY	$96.86 - $114.01 $193 - $228	2 Added 0.02%	8,830 $894,000
Q4 2022 Feb 03, 2023	SELL	$95.06 - $111.52 $4,753 - $5,576	-50 Reduced 0.56%	8,828 $969,000
Q3 2022 Nov 10, 2022	BUY	$96.76 - $112.03 $42,864 - $49,629	443 Added 5.25%	8,878 $859,000
Q2 2022 Aug 11, 2022	BUY	$102.07 - $123.37 $102 - $123	1 Added 0.01%	8,435 $916,000
Q1 2022 May 10, 2022	BUY	$114.02 - $139.04 $228 - $278	2 Added 0.02%	8,434 $998,000
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $17,098 - $20,936	-148 Reduced 1.72%	8,432 $1.19 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $233 - $258	2 Added 0.02%	8,580 $1.01 Million
Q2 2021 Aug 05, 2021	SELL	$105.79 - $124.53 $6,241 - $7,347	-59 Reduced 0.68%	8,578 $994,000
Q1 2021 May 14, 2021	BUY	$108.84 - $128.23 $108 - $128	1 Added 0.01%	8,637 $1.04 Million
Q4 2020 Feb 11, 2021	SELL	$105.0 - $114.42 $33,285 - $36,271	-317 Reduced 3.54%	8,636 $946,000
Q3 2020 Nov 13, 2020	BUY	$91.64 - $111.29 $91 - $111	1 Added 0.01%	8,953 $974,000
Q2 2020 Aug 07, 2020	BUY	$76.57 - $98.0 $76 - $98	1 Added 0.01%	8,952 $818,000
Q1 2020 May 08, 2020	BUY	$62.82 - $91.86 $125 - $183	2 Added 0.02%	8,951 $706,000
Q4 2019 Feb 03, 2020	BUY	$78.51 - $87.4 $78 - $87	1 Added 0.01%	8,949 $777,000
Q3 2019 Nov 01, 2019	BUY	$81.84 - $88.74 $163 - $177	2 Added 0.02%	8,948 $749,000
Q2 2019 Jul 29, 2019	BUY	$72.88 - $85.0 $72 - $85	1 Added 0.01%	8,946 $752,000
Q1 2019 Apr 24, 2019	BUY	$66.22 - $80.06 $132 - $160	2 Added 0.02%	8,945 $715,000
Q4 2018 Jan 24, 2019	BUY	$65.56 - $74.27 $586,303 - $664,196	8,943 New	8,943 $647,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eldridge Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Eldridge Investment Advisors, Inc. with notifications on news.

Account

Eldridge Investment Advisors, Inc. Abbott Laboratories Transaction History